Modulation of SR Ca 2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 10, 2012, Pages

  Kučerová, Dana ^a   Baba, Hideo A ^b   Bokník, Peter ^a   Fabritz, Larissa ^a,c   Heinick, Alexander ^a   Mát'uš, Marek ^d   Müller, Frank U ^a   Neumann, Joachim ^e   Schmitz, Wilhelm ^a   Kirchhefer, Uwe ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Physics and Informatics   (Slovakia)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Calcium signaling; Contractility; Heart failure; Overexpression; Sarcoplasmic reticulum

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; CALSEQUESTRIN; MEMBRANE PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TRIADIN; UNCLASSIFIED DRUG; CALCIUM; CARRIER PROTEIN; MUSCLE PROTEIN; TRDN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE WALL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CYTOLOGY; DISEASE MODEL; FIBROSIS; GENETICS; HEART CONTRACTION; HEART FAILURE; HEART VENTRICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CALSEQUESTRIN; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FIBROSIS; HEART FAILURE; HEART VENTRICLES; MICE; MICE, TRANSGENIC; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84861123379     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00457.2011     Document Type: Article

References (37)

1. Altschafl BA, Arvanitis DA, Fuentes O, Yuan Q, Kranias EG, Valdivia HH. Dual role of junctin in the regulation of ryanodine receptors and calcium release in cardiac ventricular myocytes. J Physiol 589: 6063-6080, 2011.
2. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ, de Tombe PP. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res 101: 195-204, 2007.
3. Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 37: 417-429, 2004.
4. 2+ release units, impaired excitationcontraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci USA 106: 7636-7641, 2009.
5. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110: 2651-2657, 2004.
6. 2+ delivery system in muscle cells. Appl Physiol Nutr Metab 34: 323-327, 2009.
7. 2+ handling, contractility, and heart failure. Am J Physiol Heart Circ Physiol 293: H728-H734, 2007.
8. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 266: 9180-9185, 1991.
9. Gyorke I, Hester N, Jones LR, Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 86: 2121-2128, 2004.
10. Gyorke S, Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res 77: 245-255, 2008.
11. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol 92, Suppl 1: 87-93, 1997.
12. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 101: 1385-1393, 1998.
13. 2+ in myocytes from aortic-banded rats. Circulation 94: 2915-2922, 1996.
14. 2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc Res 62: 122-134, 2004.
15. Kirchhefer U, Neumann J, Baba HA, Begrow F, Kobayashi YM, Reinke U, Schmitz W, Jones LR. Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem 276: 4142-4149, 2001.
16. Kirchhefer U, Neumann J, Bers DM, Buchwalow IB, Fabritz L, Hanske G, Justus I, Riemann B, Schmitz W, Jones LR. Impaired relaxation in transgenic mice overexpressing junctin. Cardiovasc Res 59: 369-379, 2003.
17. Kirchhefer U, Wehrmeister D, Postma AV, Pohlentz G, Mormann M, Kucerova D, Muller FU, Schmitz W, Schulze-Bahr E, Wilde AA, Neumann J. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. J Mol Cell Cardiol 49: 95-105, 2010.
18. Kirchhof P, Klimas J, Fabritz L, Zwiener M, Jones LR, Schafers M, Hermann S, Boknik P, Schmitz W, Breithardt G, Kirchhefer U, Neumann J. Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin. J Mol Cell Cardiol 42: 962-971, 2007.
19. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 116: 2510-2520, 2006.
20. Kobayashi YM, Alseikhan BA, Jones LR. Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction. J Biol Chem 275: 17639-17646, 2000.
21. Kobayashi YM, Jones LR. Identification of triadin 1 as the predominant triadin isoform expressed in mammalian myocardium. J Biol Chem 274: 28660-28668, 1999.
22. Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A, Ochodnicky P, Klimas J, Kyselovic J. Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. Eur J Heart Fail 11: 140-146, 2009.
23. Lehnart SE, Maier LS, Hasenfuss G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev 14: 213-224, 2009.
24. Lewin G, Matus M, Basu A, Frebel K, Rohsbach SP, Safronenko A, Seidl MD, Stumpel F, Buchwalow I, Konig S, Engelhardt S, Lohse MJ, Schmitz W, Muller FU. Critical role of transcription factor cyclic AMP response element modulator in beta1-adrenoceptor-mediated cardiac dysfunction. Circulation 119: 79-88, 2009.
25. Litwin SE, Morgan JP. Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res 71: 797-807, 1992.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
27. 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem 263: 1376-1381, 1988.
28. Muth JN, Bodi I, Lewis W, Varadi G, Schwartz A. A Ca(2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 103: 140-147, 2001.
29. Muth JN, Yamaguchi H, Mikala G, Grupp IL, Lewis W, Cheng H, Song LS, Lakatta EG, Varadi G, Schwartz A. Cardiac-specific overexpression of the alpha(1) subunit of the L-type voltage-dependent Ca(2+) channel in transgenic mice. Loss of isoproterenol-induced contraction. J Biol Chem 274: 21503-21506, 1999.
30. 2+ regulation. J Biol Chem 278: 16176-16182, 2003.
31. 2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem 274: 2556-2562, 1999.
32. Porzio MA, Pearson AM. Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim Biophys Acta 490: 27-34, 1977.
33. Postma AV, Denjoy I, Hoorntje TM, Lupoglazoff JM, Da CA, Sebillon P, Mannens MM, Wilde AA, Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 91: e21-e26, 2002.
34. Priori SG, Napolitano C. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. J Clin Invest 115: 2033-2038, 2005.
35. Sato Y, Ferguson DG, Sako H, Dorn GW, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 273: 28470-28477, 1998.
36. Terentyev D, Viatchenko-Karpinski S, Vedamoorthyrao S, Oduru S, Gyorke I, Williams SC, Gyorke S. Protein protein interactions between triadin and calsequestrin are involved in modulation of sarcoplasmic reticulum calcium release in cardiac myocytes. J Physiol 583: 71-80, 2007.
37. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 272: 23389-23397, 1997.